Skip to Main Content

Author Details

Donna Voeller
Center for Cancer Research, National Cancer Institute
1992
43
22
PMIDPaper TitleJournal TitlePublished Year
36470425Flotillin-2 regulates epidermal growth factor receptor activation, degradation by Cbl-mediated ubiquitination, and cancer growth.J Biol Chem2023
36470425Flotillin-2 regulates epidermal growth factor receptor activation, degradation by Cbl-mediated ubiquitination, and cancer growth.J Biol Chem2023
37046596Targeting Mitochondria with ClpP Agonists as a Novel Therapeutic Opportunity in Breast Cancer.Cancers (Basel)2023
37046596Targeting Mitochondria with ClpP Agonists as a Novel Therapeutic Opportunity in Breast Cancer.Cancers (Basel)2023
36516994Photochemical Dimerization of Plakinidine B Leads to Potent Inhibition of the E3 Ubiquitin-Protein Ligase CBL-B.Org Lett2022
36516994Photochemical Dimerization of Plakinidine B Leads to Potent Inhibition of the E3 Ubiquitin-Protein Ligase CBL-B.Org Lett2022
34202500Agelasine Diterpenoids and Cbl-b Inhibitory Ageliferins from the Coralline Demosponge <i>Astrosclera willeyana</i>.Mar Drugs2021
33882749In Vitro Ubiquitination Platform Identifies Methyl Ellipticiniums as Ubiquitin Ligase Inhibitors.SLAS Discov2021
34202500Agelasine Diterpenoids and Cbl-b Inhibitory Ageliferins from the Coralline Demosponge <i>Astrosclera willeyana</i>.Mar Drugs2021
34038132Sinularamides A-G, Terpenoid-Derived Spermidine and Spermine Conjugates with Casitas B-Lineage Lymphoma Proto-Oncogene B (Cbl-b) Inhibitory Activities from a <i>Sinularia</i> sp. Soft Coral.J Nat Prod2021
33882749In Vitro Ubiquitination Platform Identifies Methyl Ellipticiniums as Ubiquitin Ligase Inhibitors.SLAS Discov2021
34038132Sinularamides A-G, Terpenoid-Derived Spermidine and Spermine Conjugates with Casitas B-Lineage Lymphoma Proto-Oncogene B (Cbl-b) Inhibitory Activities from a <i>Sinularia</i> sp. Soft Coral.J Nat Prod2021
33126420Suberitamides A-C, Aryl Alkaloids from a <i>Pseudosuberites</i> sp. Marine Sponge that Inhibit Cbl-b Ubiquitin Ligase Activity.Mar Drugs2020
33126420Suberitamides A-C, Aryl Alkaloids from a <i>Pseudosuberites</i> sp. Marine Sponge that Inhibit Cbl-b Ubiquitin Ligase Activity.Mar Drugs2020
31120930Cbl interacts with multiple E2s in vitro and in cells.PLoS One2019
31120930Cbl interacts with multiple E2s in vitro and in cells.PLoS One2019
29719618ONC201 kills breast cancer cells <i>in vitro</i> by targeting mitochondria.Oncotarget2018
29719618ONC201 kills breast cancer cells <i>in vitro</i> by targeting mitochondria.Oncotarget2018
27078848CRKL mediates EML4-ALK signaling and is a potential therapeutic target for ALK-rearranged lung adenocarcinoma.Oncotarget2016
26759246The TRAIL receptor agonist drozitumab targets basal B triple-negative breast cancer cells that express vimentin and Axl.Breast Cancer Res Treat2016
27078848CRKL mediates EML4-ALK signaling and is a potential therapeutic target for ALK-rearranged lung adenocarcinoma.Oncotarget2016
26759246The TRAIL receptor agonist drozitumab targets basal B triple-negative breast cancer cells that express vimentin and Axl.Breast Cancer Res Treat2016
25591736LAMC2 enhances the metastatic potential of lung adenocarcinoma.Cell Death Differ2015
25591736LAMC2 enhances the metastatic potential of lung adenocarcinoma.Cell Death Differ2015
24974848A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors.Nat Genet2014
24974848A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors.Nat Genet2014
23577124Whole genome and transcriptome sequencing of a B3 thymoma.PLoS One2013
23444221Copy number aberrations of genes regulating normal thymus development in thymic epithelial tumors.Clin Cancer Res2013
23577124Whole genome and transcriptome sequencing of a B3 thymoma.PLoS One2013
23444221Copy number aberrations of genes regulating normal thymus development in thymic epithelial tumors.Clin Cancer Res2013
21731696MicroRNA expression and clinical outcome of small cell lung cancer.PLoS One2011
22101337Poly(ADP-ribose) polymerase inhibition enhances p53-dependent and -independent DNA damage responses induced by DNA damaging agent.Cell Cycle2011
21731696MicroRNA expression and clinical outcome of small cell lung cancer.PLoS One2011
22101337Poly(ADP-ribose) polymerase inhibition enhances p53-dependent and -independent DNA damage responses induced by DNA damaging agent.Cell Cycle2011
20811718Enhanced growth inhibition by combined DNA methylation/HDAC inhibitors in lung tumor cells with silenced CDKN2A.Int J Oncol2010
20811718Enhanced growth inhibition by combined DNA methylation/HDAC inhibitors in lung tumor cells with silenced CDKN2A.Int J Oncol2010
17297449Transgenic expression of human thymidylate synthase accelerates the development of hyperplasia and tumors in the endocrine pancreas.Oncogene2007
17297449Transgenic expression of human thymidylate synthase accelerates the development of hyperplasia and tumors in the endocrine pancreas.Oncogene2007
15093541Thymidylate synthase as an oncogene: a novel role for an essential DNA synthesis enzyme.Cancer Cell2004
15280655Elevated levels of thymidylate synthase linked to neoplastic transformation of mammalian cells.Cell Cycle2004
15093541Thymidylate synthase as an oncogene: a novel role for an essential DNA synthesis enzyme.Cancer Cell2004
15280655Elevated levels of thymidylate synthase linked to neoplastic transformation of mammalian cells.Cell Cycle2004
12220503The identification of thymidylate synthase peptide domains located in the interface region that bind thymidylate synthase mRNA.Biochem Biophys Res Commun2002
12220503The identification of thymidylate synthase peptide domains located in the interface region that bind thymidylate synthase mRNA.Biochem Biophys Res Commun2002
11460003Development of human anti-thymidine kinase antibodies.Anticancer Drugs2001
11460003Development of human anti-thymidine kinase antibodies.Anticancer Drugs2001
10684933Characterization of a cis-acting regulatory element in the protein coding region of thymidylate synthase mRNA.Nucleic Acids Res2000
10684933Characterization of a cis-acting regulatory element in the protein coding region of thymidylate synthase mRNA.Nucleic Acids Res2000
10803925Identification and proposed mechanism of action of thymidine kinase inhibition associated with cellular exposure to camptothecin analogs.Cancer Chemother Pharmacol2000
10803925Identification and proposed mechanism of action of thymidine kinase inhibition associated with cellular exposure to camptothecin analogs.Cancer Chemother Pharmacol2000
  • 1 - 50 of 86

Recommended Authors

Kristen Jensen-Pergakes
Pfizer Inc. San Diego
Career Start Year 1998
Number of shared co-authors 0
Mahadev Rao
Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences
Career Start Year 1998
Number of shared co-authors 7
Ann-Sofie Jemth
Karolinska Institutet
Career Start Year 1997
Number of shared co-authors 0
Ailan Guo
College of Animal Medicine, Xinjiang Agricultural University
Career Start Year 1992
Number of shared co-authors 0
Loren Miraglia
Genomics Institute of the Novartis Research Foundation
Career Start Year 1991
Number of shared co-authors 0
Alessandro Datti
University of Perugia
Career Start Year 1991
Number of shared co-authors 0
Philip J R Day
University of Cape Town
Career Start Year 1988
Number of shared co-authors 0
Timothy C Burn
Incyte Research Institute
Career Start Year 1987
Number of shared co-authors 0
Stefan W??lfl
Institute of Pharmacy and Molecular Biotechnology, Heidelberg University
Career Start Year 1987
Number of shared co-authors 0
Satyajit Ray
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1986
Number of shared co-authors 5
Stuart L Schreiber
Broad Institute
Career Start Year 1985
Number of shared co-authors 1
Alan Ashworth
UCSF Helen Diller Family Comprehensive Cancer Center
Career Start Year 1982
Number of shared co-authors 0
John A Copland
Mayo Clinic Jacksonville
Career Start Year 1982
Number of shared co-authors 4
Mary Eileen Dolan
University of Chicago
Career Start Year 1981
Number of shared co-authors 0
Alexander Kamb
Inc. 30301 Agoura Rd.
Career Start Year 1979
Number of shared co-authors 1
Fabien Calvo
Universite de Paris-Cite
Career Start Year 1979
Number of shared co-authors 0
Robert H Shoemaker
National Cancer Institute
Career Start Year 1978
Number of shared co-authors 7
Chi V Dang
Johns Hopkins University School of Medicine
Career Start Year 1978
Number of shared co-authors 0
Scott H Kaufmann
Mayo Clinic
Career Start Year 1977
Number of shared co-authors 1
Christopher C Benz
Buck Institute for Research on Aging
Career Start Year 1977
Number of shared co-authors 4
Anne Monks
Institute of Biomedical Engineering (IBME), University of Oxford
Career Start Year 1976
Number of shared co-authors 6
James Koropatnick
Western University, Lawson Health Research Institute
Career Start Year 1975
Number of shared co-authors 0
Hiroshi Handa
Center for Future Medical Research, Tokyo Medical University
Career Start Year 1975
Number of shared co-authors 0
Paul Workman
The Institute of Cancer Research
Career Start Year 1974
Number of shared co-authors 0
Stephen B Howell
Moores Cancer Center and Department of Medicine, University of California
Career Start Year 1974
Number of shared co-authors 0
Peter J Houghton
The University of Texas Health Science Center at San Antonio
Career Start Year 1971
Number of shared co-authors 7
Garth Powis
PHusis Therapeutics Inc.
Career Start Year 1970
Number of shared co-authors 0
Tony Hunter
Salk Institute for Biological Studies
Career Start Year 1968
Number of shared co-authors 0
John N Weinstein
The University of Texas MD Anderson Cancer Center
Career Start Year 1968
Number of shared co-authors 8
Robert B Diasio
Mayo Clinic
Career Start Year 1965
Number of shared co-authors 0

Collaborators

Stanley Lipkowitz
Center for Cancer Research, National Cancer Institute
Co-authored papers 11
Giuseppe Giaccone
Meyer Cancer Center
Co-authored papers 7
Yisong Wang
Lombardi Comprehensive Cancer Center, Georgetown University
Co-authored papers 5
Patricia S Steeg
Center for Cancer Research, National Cancer Institute
Co-authored papers 3
Yves Pommier
Center for Cancer Research, National Cancer Institute
Co-authored papers 3
Iacopo Petrini
University of Pisa
Co-authored papers 3
Trung Pham
Stanford University
Co-authored papers 3
James Gao
National Eye Institute, National Institutes of Health
Co-authored papers 2
Paul S Meltzer
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
David M Koeller
Oregon Health & Science University
Co-authored papers 1
William Marston Linehan
Co-authored papers 1
Qing-Rong Chen
Center for Biomedical Informatics and Information Technology
Co-authored papers 1
Vinodh N Rajapakse
Co-authored papers 1
Monzur Rahman
Center for Cancer Research, National Cancer Institute
Co-authored papers 1
Markus Hafner
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Co-authored papers 1
William C Reinhold
Center for Cancer Research, National Cancer Institute
Co-authored papers 1
Robert L Walker
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
Arjan Gower
David Geffen School of Medicine at University of California at Los Angeles
Co-authored papers 1
Maggie Cam
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
Udayan Guha
Co-authored papers 1
Kunio Nagashima
Co-authored papers 1
Lionel Feigenbaum
Science Applications International Corporation/Frederick
Co-authored papers 1
Jonathan K Killian
From Foundation Medicine
Co-authored papers 1
Marbin Pineda
Center for Cancer Research, National Cancer Institute
Co-authored papers 1
Yuelin J Zhu
National Cancer Institute, National Institutes of Health
Co-authored papers 1
Arun Rajan
Center for Cancer Research, National Cancer Institute
Co-authored papers 1
Sean Davis
Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington
Co-authored papers 1
Susan R Davis
Co-authored papers 1
Stephen M Hewitt
Center for Cancer Research, National Cancer Institute
Co-authored papers 1
J. Carl Barrett
Oncology R&D
Co-authored papers 1
Release 1.2